Spyre Therapeutics Inc

NEW
FRA:3920 (USA)  
€ 75.5 +1.5 (+2.03%) Sep 11
At Loss
P/B:
8.36
Market Cap:
€ 6.88B ($ 7.95B)
Enterprise V:
€ 6.02B ($ 6.96B)
Volume:
0
Avg Vol (2M):
125.00
Trade In:

Spyre Therapeutics Inc (FRA:3920) Dividend

Spyre Therapeutics Inc (FRA:3920) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -210.4%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: FRA:3920 Dividend

Does Spyre Therapeutics Inc (FRA:3920) pay a dividend?

Spyre Therapeutics Inc (FRA:3920) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Spyre Therapeutics Inc pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Spyre Therapeutics Inc has returned capital to shareholders via buybacks at a rate of -210.4% over the past 3 years.

What are dividend-paying alternatives to Spyre Therapeutics Inc?

For dividend-paying alternatives in Spyre Therapeutics Inc's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.